Open Access
Open access
volume 83 issue 6 pages ard-2023-224416

EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis

Ioannis Parodis 1, 2, 3, 4, 5, 6
Charlotte Girard-Guyonvarc’h 7, 8, 9, 10
L. Arnaud 11, 12
O Distler 13, 14
Andrea Domján 15, 16
Cornelia H.M. van den Ende 11, 17, 18, 19
Kim Fligelstone 20
Agnes Kocher 21, 22
Maddalena Larosa 23, 24
Martin Lau 25
Alexandros Mitropoulos 26, 27
Mwidimi Ndosi 28, 29
Janet L. Poole 30, 31
Anthony Redmond 32, 33
Valentin Ritschl 34, 35, 36
Helene Alexanderson 1, 2, 4, 37
Yvonne Sjöberg 38
Gunilla Von Perner 38
Till Uhlig 39, 40
Cecilia Varju 41, 42
Johanna E. Vriezekolk 17, 18
Elisabet Welin 6, 43
R Westhovens 44, 45
Tanja A Stamm 34, 35, 36
Carina Boström 2, 4, 37, 46
1
 
Division of Rheumatology, Department of Medicine Solna
3
 
Department of Gastroenterology, Dermatology and Rheumatology
5
 
Department of Rheumatology, Faculty of Medicine and Health
7
 
Division of Rheumatology, Department of Medicine
9
 
Faculty of Medicine
11
 
Department of Rheumatology
15
 
Department of Rheumatology, Faculty of Medicine
17
 
Department of Research
20
 
Federation of European Scleroderma Associations (FESCA)
21
 
Institute of Nursing Science, Faculty of Medicine
23
 
Rheumatology Unit, Department of Medical Specialties
24
 
ASL3
25
 
Arthritis Action
26
 
Department of Nursing and Midwifery, College of Health Wellbeing and Life Science
28
 
School of Health and Social Wellbeing
30
 
Occupational Therapy Graduate Program, School of Medicine
31
 
University Of New Mexico
32
 
Leeds Institute for Rheumatic and Musculoskeletal Medicine
34
 
Section for Outcomes Research, Center for Medical Statistics, Informatics and Intelligent Systems
37
 
Department of Occupational Therapy and Physiotherapy
38
 
Swedish Rheumatism Association
39
 
Center for Treatment of Rheumatic and Musculoskeletal Diseases
41
 
Department of Rheumatology and Immunology
43
 
School of Health Sciences
44
 
Skeletal Biology and Engineering Research Center
45
 
46
 
Division of Physiotherapy, Department of Neurobiology, Care Sciences and Society
Publication typeJournal Article
Publication date2023-07-10
scimago Q1
wos Q1
SJR5.731
CiteScore33.2
Impact factor20.6
ISSN00034967, 14682060
General Biochemistry, Genetics and Molecular Biology
Immunology
Immunology and Allergy
Rheumatology
Abstract
Objective

To develop evidence-based recommendations for the non-pharmacological management of systemic lupus erythematosus (SLE) and systemic sclerosis (SSc).

Methods

A task force comprising 7 rheumatologists, 15 other healthcare professionals and 3 patients was established. Following a systematic literature review performed to inform the recommendations, statements were formulated, discussed during online meetings and graded based on risk of bias assessment, level of evidence (LoE) and strength of recommendation (SoR; scale A–D, A comprising consistent LoE 1 studies, D comprising LoE 4 or inconsistent studies), following the European Alliance of Associations for Rheumatology standard operating procedure. Level of agreement (LoA; scale 0–10, 0 denoting complete disagreement, 10 denoting complete agreement) was determined for each statement through online voting.

Results

Four overarching principles and 12 recommendations were developed. These concerned common and disease-specific aspects of non-pharmacological management. SoR ranged from A to D. The mean LoA with the overarching principles and recommendations ranged from 8.4 to 9.7. Briefly, non-pharmacological management of SLE and SSc should be tailored, person-centred and participatory. It is not intended to preclude but rather complement pharmacotherapy. Patients should be offered education and support for physical exercise, smoking cessation and avoidance of cold exposure. Photoprotection and psychosocial interventions are important for SLE patients, while mouth and hand exercises are important in SSc.

Conclusions

The recommendations will guide healthcare professionals and patients towards a holistic and personalised management of SLE and SSc. Research and educational agendas were developed to address needs towards a higher evidence level, enhancement of clinician–patient communication and improved outcomes.

Found 
Found 

Top-30

Journals

1
2
3
4
5
6
Rheumatology
6 publications, 7.41%
Lupus Science and Medicine
5 publications, 6.17%
Rheumatology International
5 publications, 6.17%
RMD Open
4 publications, 4.94%
Annals of the Rheumatic Diseases
4 publications, 4.94%
Die Innere Medizin
3 publications, 3.7%
Zeitschrift fur Rheumatologie
3 publications, 3.7%
Autoimmunity Reviews
3 publications, 3.7%
Journal of Scleroderma and Related Disorders
3 publications, 3.7%
Rheumatology Advances in Practice
2 publications, 2.47%
Arthritis Care and Research
2 publications, 2.47%
The Lancet Rheumatology
2 publications, 2.47%
Current Treatment Options in Rheumatology
2 publications, 2.47%
Arthritis und Rheuma
2 publications, 2.47%
Evidence-based nursing
1 publication, 1.23%
Revue du Rhumatisme (Edition Francaise)
1 publication, 1.23%
Journal of Clinical Rheumatology
1 publication, 1.23%
Deutsche Dermatologie
1 publication, 1.23%
Expert Review of Clinical Immunology
1 publication, 1.23%
Expert Opinion on Pharmacotherapy
1 publication, 1.23%
Rheumato
1 publication, 1.23%
International Journal of Molecular Sciences
1 publication, 1.23%
SSM - Qualitative Research in Health
1 publication, 1.23%
Rheumatology and Therapy
1 publication, 1.23%
BMJ Open Sport and Exercise Medicine
1 publication, 1.23%
Nursing Clinics of North America
1 publication, 1.23%
Current Opinion in Rheumatology
1 publication, 1.23%
Journal of Pharmaceutical Innovation
1 publication, 1.23%
Lupus
1 publication, 1.23%
Reviews in Cardiovascular Medicine
1 publication, 1.23%
1
2
3
4
5
6

Publishers

5
10
15
20
Springer Nature
20 publications, 24.69%
Elsevier
13 publications, 16.05%
BMJ
11 publications, 13.58%
Oxford University Press
8 publications, 9.88%
MDPI
6 publications, 7.41%
Wiley
5 publications, 6.17%
SAGE
5 publications, 6.17%
Taylor & Francis
3 publications, 3.7%
Ovid Technologies (Wolters Kluwer Health)
2 publications, 2.47%
Georg Thieme Verlag KG
2 publications, 2.47%
IMR Press
1 publication, 1.23%
OAE Publishing Inc.
1 publication, 1.23%
Mediar Press
1 publication, 1.23%
European Respiratory Society (ERS)
1 publication, 1.23%
American Medical Association (AMA)
1 publication, 1.23%
Frontiers Media S.A.
1 publication, 1.23%
5
10
15
20
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
81
Share
Cite this
GOST |
Cite this
GOST Copy
Parodis I. et al. EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis // Annals of the Rheumatic Diseases. 2023. Vol. 83. No. 6. p. ard-2023-224416.
GOST all authors (up to 50) Copy
Parodis I. et al. EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis // Annals of the Rheumatic Diseases. 2023. Vol. 83. No. 6. p. ard-2023-224416.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1136/ard-2023-224416
UR - https://doi.org/10.1136/ard-2023-224416
TI - EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis
T2 - Annals of the Rheumatic Diseases
AU - Parodis, Ioannis
AU - Girard-Guyonvarc’h, Charlotte
AU - Arnaud, L.
AU - Distler, O
AU - Domján, Andrea
AU - van den Ende, Cornelia H.M.
AU - Fligelstone, Kim
AU - Kocher, Agnes
AU - Larosa, Maddalena
AU - Lau, Martin
AU - Mitropoulos, Alexandros
AU - Ndosi, Mwidimi
AU - Poole, Janet L.
AU - Redmond, Anthony
AU - Ritschl, Valentin
AU - Alexanderson, Helene
AU - Sjöberg, Yvonne
AU - Von Perner, Gunilla
AU - Uhlig, Till
AU - Varju, Cecilia
AU - Vriezekolk, Johanna E.
AU - Welin, Elisabet
AU - Westhovens, R
AU - Stamm, Tanja A
AU - Boström, Carina
PY - 2023
DA - 2023/07/10
PB - Elsevier
SP - ard-2023-224416
IS - 6
VL - 83
PMID - 37433575
SN - 0003-4967
SN - 1468-2060
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2023_Parodis,
author = {Ioannis Parodis and Charlotte Girard-Guyonvarc’h and L. Arnaud and O Distler and Andrea Domján and Cornelia H.M. van den Ende and Kim Fligelstone and Agnes Kocher and Maddalena Larosa and Martin Lau and Alexandros Mitropoulos and Mwidimi Ndosi and Janet L. Poole and Anthony Redmond and Valentin Ritschl and Helene Alexanderson and Yvonne Sjöberg and Gunilla Von Perner and Till Uhlig and Cecilia Varju and Johanna E. Vriezekolk and Elisabet Welin and R Westhovens and Tanja A Stamm and Carina Boström and others},
title = {EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis},
journal = {Annals of the Rheumatic Diseases},
year = {2023},
volume = {83},
publisher = {Elsevier},
month = {jul},
url = {https://doi.org/10.1136/ard-2023-224416},
number = {6},
pages = {ard--2023--224416},
doi = {10.1136/ard-2023-224416}
}
MLA
Cite this
MLA Copy
Parodis, Ioannis, et al. “EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis.” Annals of the Rheumatic Diseases, vol. 83, no. 6, Jul. 2023, pp. ard-2023-224416. https://doi.org/10.1136/ard-2023-224416.